{
    "organizations": [],
    "uuid": "646ee6a6967431efe7b3d0f790d16ea3d30cc2b0",
    "author": "",
    "url": "https://www.reuters.com/article/brief-novoheart-signs-agreement-with-sum/brief-novoheart-signs-agreement-with-sumocor-to-develop-therapeutics-for-heart-failure-idUSFWN1Q41AC",
    "ord_in_thread": 0,
    "title": "BRIEF-Novoheart Signs Agreement With Sumocor To Develop Therapeutics For Heart Failure",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 14, 2018 / 2:22 PM / in 4 minutes BRIEF-Novoheart Signs Agreement With Sumocor To Develop Therapeutics For Heart Failure Reuters Staff Feb 14 (Reuters) - Novoheart Holdings Inc: * NOVOHEART SIGNS AGREEMENT WITH SUMOCOR TO DEVELOP NOVEL THERAPEUTICS FOR HEART FAILURE * NOVOHEART HOLDINGS INC - CO, THROUGH ITS U.S. UNIT, HAS ENTERED INTO A COMMERCIAL AGREEMENT WITH SUMOCOR LLC * NOVOHEART - AS PER AGREEMENT, CO WILL TEST SUMOCOR‘S CANDIDATE THERAPEUTICS IN 3 PHASES ON CO‘S MYHEART PLATFORM OF HUMAN BIOENGINEERED HEART CONSTRUCTS Source text for Eikon: Further company coverage:",
    "published": "2018-02-14T16:18:00.000+02:00",
    "crawled": "2018-02-14T16:34:02.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "sign",
        "agreement",
        "sumocor",
        "develop",
        "therapeutic",
        "heart",
        "failure",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "novoheart",
        "holding",
        "inc",
        "novoheart",
        "sign",
        "agreement",
        "sumocor",
        "develop",
        "novel",
        "therapeutic",
        "heart",
        "failure",
        "novoheart",
        "holding",
        "inc",
        "co",
        "unit",
        "entered",
        "commercial",
        "agreement",
        "sumocor",
        "llc",
        "novoheart",
        "per",
        "agreement",
        "co",
        "test",
        "sumocor",
        "candidate",
        "therapeutic",
        "phase",
        "co",
        "myheart",
        "platform",
        "human",
        "bioengineered",
        "heart",
        "construct",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}